Media and Investors Resources

Press Release, 15 April 2025

Adhoc Press Release

Kuros Biosciences reports 82% year over year increase in sales in the first three months of 2025

U.S. Stock Option and Equity Incentive Plan Regulation 2025

Kuros Annual Report, 2024

English version

Press Release, 11 March 2025

Adhoc Press Release

Kuros Biosciences grows sales to CHF 75.6 million for 2024

Press Release, 7 January 2025

Adhoc Press Release

Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the Medtronic spinal division

Press Release, 19 November 2024

Kuros Biosciences Expands into Extremities Markets